7 hours ago
2
CeriBell (NASDAQ:CBLL) said on Monday that it has taken legal action against Natus Medical and its units, claiming that they have infringed on its patents and engaged in unfair competition.
Ceribell has requested that the U.S. International Trade Commission investigate its
English (US) ·